Researchers have developed self-assembling peptide nanotubes that deliver doxorubicin directly into the nucleus of ...
A new PNAS study unveils a hidden vulnerability of prostate cancer: the protein-disulfide isomerases , which stabilize (AR) ...
Researchers at the Institut Pasteur and Inserm have developed a novel triple-therapy that reprograms how B cell cancers ...
Researchers have developed a groundbreaking LED-based cancer therapy using tin oxide (SnOx) nanoflakes that selectively ...
Bristol Myers Squibb (BMS) has announced the acquisition of Orbital Therapeutics, a privately held biotech specializing in ...
FDA Approves Libtayo as First Adjuvant Immunotherapy for High-Risk Cutaneous Squamous Cell Carcinoma
The FDA has approved the PD-1 inhibitor Libtayo® (cemiplimab-rwlc) as the first and only immunotherapy for the adjuvant ...
The Phase III TROPION-Breast02 trial demonstrated that datopotamab deruxtecan (Datroway) achieved a statistically significant ...
AstraZeneca has reached a wide-ranging agreement with the Trump administration to cut prescription drug prices for American patients—offering up to 80% discounts via TrumpRx.gov—while investing $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback